Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trial

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00091-9/fulltext?dgcid=hubspot_update_feature_updatealerts_lanonc&utm_campaign=update-lanonc&utm_medium=email&_hsenc=p2ANqtz-872pDITdjeZfRIyLx2zCGb40jYuVL7WBih1q1wjB5xrMm86W4EPBdhFG7gcTcDlyPMUcJeDseYsxmdQeQDig4mtggEDA&_hsmi=356617651&utm_content=356548210&utm_source=hs_email